AngioDynamics, Inc. (ANGO)
NASDAQ: ANGO · Real-Time Price · USD
11.00
-0.10 (-0.86%)
Apr 28, 2026, 4:00 PM EDT - Market closed
AngioDynamics Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for AngioDynamics stock have an average target of 18, with a low estimate of 16 and a high estimate of 24. The average target predicts an increase of 63.71% from the current stock price of 11.00.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for AngioDynamics stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 5 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Freedom Broker | Freedom Broker | Strong Buy Initiates $16 | Strong Buy | Initiates | $16 | +45.52% | Apr 6, 2026 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $18 → $16 | Strong Buy | Maintains | $18 → $16 | +45.52% | Apr 6, 2026 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $17 → $18 | Strong Buy | Maintains | $17 → $18 | +63.71% | Oct 3, 2025 |
| Lake Street | Lake Street | Strong Buy Initiates $24 | Strong Buy | Initiates | $24 | +118.28% | Jul 16, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +45.52% | Jul 16, 2025 |
Financial Forecast
Revenue This Year
320.30M
from 292.50M
Increased by 9.51%
Revenue Next Year
336.19M
from 320.30M
Increased by 4.96%
EPS This Year
-0.25
from -0.83
EPS Next Year
-0.18
from -0.25
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 330.3M | 347.6M | |||
| Avg | 320.3M | 336.2M | |||
| Low | 307.2M | 320.9M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 12.9% | 8.5% | |||
| Avg | 9.5% | 5.0% | |||
| Low | 5.0% | 0.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -0.18 | -0.08 | |||
| Avg | -0.25 | -0.18 | |||
| Low | -0.28 | -0.26 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.